| Study population n = 366 | Controls n = 60 | p |
---|---|---|---|
Age, yrs | 52.5 ± 12.1 | 54.2 ± 9.1 | 0.29 |
Male | 206 (56.3) | 33/60b | 0.85 |
BMI, kg/m2 | 21.9 ± 3.4 | 25.5 ± 2.9 | <0.001 |
Current Smoker | 80 (21.9) | 11/60b | 0.54 |
Dialysis Vintage, months | 58.5 (31.0 – 89.0) | -- | -- |
IDWG, kg | 2.5 ± 0.9 | -- | -- |
Diabetes Mellitus | 60 (16.4) | 2/60b | 0.005 |
History of CVD | 38 (10.4%) | -- | -- |
Use of antihypertensives | 254 (69.4) | -- | -- |
Use of ACEI/ARB | 95 (26.0) | -- | -- |
Statins | 14 (3.8) | -- | -- |
Weekly dose of EPO, IU | 6000 (4000 - 9000) | -- | -- |
Hemoglobin, g/L | 108.7 ± 16.7 | -- | -- |
Albumin, g/L | 39.5 ± 4.5 | -- | -- |
Total cholesterol, mmol/L | 3.95 ± 0.94 | -- | -- |
Triglyceride, mmol/L | 1.62 (1.17 – 2.28) | -- | -- |
HDL cholesterol, mmol/L | 1.00 ± 0.29 | -- | -- |
LDL cholesterol, mmol/L | 2.06 ± 0.59 | -- | -- |
Phosphorus, mmol/L | 1.81 ± 0.51 | -- | -- |
Calcium, mmol/L | 2.28 ± 0.26 | -- | -- |
Parathyroid hormone, pg/mL | 280.6 (109.7 – 559.5) | -- | -- |
Systolic Blood Pressure | 138.6 ± 22.7 | 124.1 ± 17.6 | <0.001 |
Diastolic Blood Pressure | 84.6 ± 12.7 | 83.0 ± 11.1 | 0.37 |
Heart Rate | 77.0 ± 10.0 | 74.7 ± 13.9 | 0.12 |
PWVa | 10.6 ± 3.5 | -- | -- |
CRP, ug/ml | 5.40 (1.73 – 14.14) | -- | -- |
BNP, pg/ml | 280.7 (103.2 – 546.4) | -- | -- |
NT proBNP, pg/ml | 500.4 (281.2 – 787.0) | -- | -- |
Troponin I, pg/ml | 57.9 (20.6 – 158.3) | -- | -- |
Troponin T, pg/ml | 67.4 (22.8 – 117.5) | -- | -- |